(MedPage Today) — The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
The nonsteroidal mineralocorticoid receptor antagonist (MRA) is the first of its class to win approval for treating…
Source link : https://www.medpagetoday.com/cardiology/chf/116492
Author :
Publish date : 2025-07-14 17:36:00
Copyright for syndicated content belongs to the linked Source.
